Adult Vaccines Market Examined in New iGATE Research Report Now Available at

21 May 2015 • by Natalie Aster

LONDON - Adult vaccines form one of the swiftest growing segments of the pharma market. It is expected to demonstrate a CAGR of approximately 6.9 percent in the upcoming years, with its growth encouraged by a number of factors, such as growing focus on flu prevention, increasing acceptance of adult vaccines, development of new products, and more. However, concerns associated with vaccine safety, entry barriers for newcomers, issues related to product shortages are amongst the key factors restraining the market growth.

Influenza vaccines enjoy the largest demand from consumers, holding the largest slice in the adult vaccines pie in 2014. Vaccinations for hepatitis form another prominent market segment. The HPV/Cervical cancer vaccines are also in the top three.

GSK, Sanofi Pasteur and Merck are currently the top players of the global marketplace, with Pfizer and Novartis lagging behind. In the meantime, the USA, Europe and Japan are the largest country-wide markets.

New market research report “Global - Adult Vaccines Market & Company Analysis to 2020” elaborated by iGATE Research Pvt. Ltd. provides a comprehensive examination of the global market for adult vaccines. The study offers a bird’s eye view of the marketplace, covering key diseases and markets. It investigates the market drivers and challenges and casts light on the market shares (by disease and by company). The report includes a disease-wise analysis of the marketplace and scrutinises the competitive environment. The research study focuses on top players and highlights regional and country markets. It looks at M&A activities and contains future market outlook.

Report Details:

Global - Adult Vaccines Market & Company Analysis to 2020
Published: May, 2015
Pages: 232
Price: US$ 1,490.00

More insightful research studies can be found at iGATE Research page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970